Figure 1.
MSCs in the tumour microenvironment affect the success of anticancer therapy. There are two potential outcomes: (A) chemotherapeutic agents induce cell death in cancer cells or (B) the interaction of cancer cells, treated with a chemotherapeutic agent, with MSCs and the extracellular matrix in the tumour microenvironment may result in an increased risk of cancer cells developing drug resistance.
